PharmaCyte Biotech, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Las Vegas, NV
SEC filing record 1 source field available
Fiscal year end
30 April
PharmaCyte Biotech, Inc. has filed 470 SEC EDGAR filings since 20 Aug 2001

SEC filing history

Showing 1-25 of 390 matching filings.

Per page
25
Current page
1
10-K File 001-40699

FORM 10-K FOR APRIL 2026

Filing date
29 Jul 2026
Reporting date
30 Apr 2026
Next action
Verify source filing
4/A

4/A filing

Filing date
17 Jul 2026
Reporting date
31 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

4/A filing

Filing date
17 Jul 2026
Reporting date
31 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

4/A filing

Filing date
17 Jul 2026
Reporting date
31 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

4/A filing

Filing date
17 Jul 2026
Reporting date
31 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
02 Apr 2026
Reporting date
31 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
02 Apr 2026
Reporting date
31 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
02 Apr 2026
Reporting date
31 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
02 Apr 2026
Reporting date
31 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-40492

4 filing

Filing date
18 Mar 2026
Reporting date
17 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G

SCHEDULE 13G filing

Filing date
18 Mar 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-40699

FORM 10-Q FOR JAN 2026

Filing date
17 Mar 2026
Reporting date
31 Jan 2026
Next action
Verify source filing
ARS File 001-40699

ANNUAL REPORT

Filing date
09 Mar 2026
Reporting date
30 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-40699

DEFINITIVE PROXY STATEMENT

Filing date
09 Mar 2026
Reporting date
30 Mar 2026
Next action
Verify source filing
PRE 14A File 001-40699

PRELIMINARY PROXY STATEMENT

Filing date
27 Feb 2026
Reporting date
30 Mar 2026
Next action
Verify source filing
SCHEDULE 13G/A File 005-91495

SCHEDULE 13G/A filing

Filing date
13 Feb 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
07 Jan 2026
Reporting date
05 Jan 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
07 Jan 2026
Reporting date
05 Jan 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-40699

FORM 10-Q FOR OCT 2025

Filing date
18 Dec 2025
Reporting date
31 Oct 2025
Next action
Verify source filing
NT 10-Q File 001-40699

EXTENSION

Filing date
15 Dec 2025
Reporting date
31 Oct 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
12 Dec 2025
Reporting date
25 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
12 Dec 2025
Reporting date
25 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
12 Dec 2025
Reporting date
12 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
12 Dec 2025
Reporting date
25 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .